Insider · CIK 0001191818

LEFKOFF KYLE

Reports to the SEC for 4 companies · BOULDER, CO

sec.gov

Transactions

Companies

Filings

CIK

0001191818

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCU Disposition from Tender	Director	UDisposition from Tender	−22.6K sh	$48.00	−$1.09M	70,085
2019-07-30	ARRAY BIOPHARMA INCD Disposition to Issuer	Director	DDisposition to Issuer	−85 sh	$48.00	−$4,080	70,000
2019-07-30	ARRAY BIOPHARMA INCD Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	65,000
2019-07-30	ARRAY BIOPHARMA INCU Disposition from Tender	Director	UDisposition from Tender	−20K sh	$48.00	−$960K	45,000
2019-07-30	ARRAY BIOPHARMA INCD Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	$48.00	−$1.44M	0
2019-07-30	ARRAY BIOPHARMA INCU Disposition from Tender	Director	UDisposition from Tender	−15K sh	$48.00	−$720K	30,000
2019-02-06	ARRAY BIOPHARMA INCM Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$10.47	+$262K	47,720
2019-02-06	ARRAY BIOPHARMA INCS Sale	Director	SSale	−25K sh	$20.51	−$513K	22,720
2019-02-06	ARRAY BIOPHARMA INCS Sale	Director	SSale	−5,000 sh	$20.82	−$104K	25,000
2019-02-06	ARRAY BIOPHARMA INCS Sale	Director	SSale	−5,000 sh	$20.85	−$104K	20,000
2019-02-06	ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	0
2018-10-26	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2018-10-26	ARRAY BIOPHARMA INCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	—	—	22,720
2018-10-25	ARRAY BIOPHARMA INCRestricted Stock UnitsA Award	Director	AAward	+5,000 sh	—	—	5,000
2018-10-25	ARRAY BIOPHARMA INCStock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2018-07-06	ARRAY BIOPHARMA INCM Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$5.13	+$128K	42,720
2018-07-06	ARRAY BIOPHARMA INCS Sale	Director	SSale	−50K sh	$17.45	−$873K	17,720
2018-07-06	ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	0
2018-07-06	ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	0
2018-07-06	ARRAY BIOPHARMA INCM Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$5.95	+$149K	67,720
2018-02-09	ARRAY BIOPHARMA INCS Sale	Director	SSale	−50K sh	$17.01	−$851K	17,720
2018-02-09	ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	0
2018-02-09	ARRAY BIOPHARMA INCM Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$3.87	+$96.8K	67,720
2018-02-09	ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	0
2018-02-09	ARRAY BIOPHARMA INCM Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$5.60	+$140K	42,720
2017-10-27	ARRAY BIOPHARMA INCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$10.47	+$52.4K	17,720
2017-10-27	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2017-10-26	ARRAY BIOPHARMA INCRestricted Stock UnitsA Award	Director	AAward	+5,000 sh	—	—	5,000
2017-10-26	ARRAY BIOPHARMA INCStock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2017-09-29	ARRAY BIOPHARMA INCS Sale	Director	SSale	−38.9K sh	$12.31	−$478K	12,720
2017-09-29	ARRAY BIOPHARMA INCM Exercise/Conversion	Director	MExercise/Conversion	+45K sh	$10.58	+$476K	51,585
2017-09-29	ARRAY BIOPHARMA INCStock OptionM Exercise/Conversion	Director	MExercise/Conversion	−45K sh	—	—	0
2017-06-28	VRDNViridian Therapeutics, Inc.\DE · Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2017-03-31	ARRAY BIOPHARMA INCM Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$3.69	+$92.3K	31,585
2017-03-31	ARRAY BIOPHARMA INCM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$4.36	+$87.2K	51,585
2017-03-31	ARRAY BIOPHARMA INCS Sale	Director	SSale	−45K sh	$8.92	−$401K	6,585
2017-03-31	ARRAY BIOPHARMA INCStock OptionM Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	0
2017-03-31	ARRAY BIOPHARMA INCStock OptionM Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2017-03-10	VRDNViridian Therapeutics, Inc.\DES Sale	Director	SSale	−3,300 sh	$14.31	−$47.2K	463,473
2017-03-09	VRDNViridian Therapeutics, Inc.\DES Sale	Director	SSale	−2,500 sh	$14.38	−$36K	466,773
2017-03-08	VRDNViridian Therapeutics, Inc.\DES Sale	Director	SSale	−5,000 sh	$14.70	−$73.5K	469,273
2017-03-06	VRDNViridian Therapeutics, Inc.\DES Sale	Director	SSale	−608 sh	$16.24	−$9,873.798	474,273
2017-03-06	VRDNViridian Therapeutics, Inc.\DES Sale	Director	SSale	−9,392 sh	$15.71	−$148K	474,881
2017-02-28	VRDNViridian Therapeutics, Inc.\DES Sale	Director	SSale	−2,258 sh	$13.54	−$30.6K	484,273
2017-02-27	VRDNViridian Therapeutics, Inc.\DES Sale	Director	SSale	−1,500 sh	$13.79	−$20.7K	486,531
2017-02-24	VRDNViridian Therapeutics, Inc.\DES Sale	Director	SSale	−6,500 sh	$14.04	−$91.3K	488,031
2017-02-23	VRDNViridian Therapeutics, Inc.\DES Sale	Director	SSale	−1,800 sh	$13.65	−$24.6K	494,531
2017-02-22	VRDNViridian Therapeutics, Inc.\DES Sale	Director	SSale	−4,102 sh	$14.36	−$58.9K	496,331
2016-11-28	ARRAY BIOPHARMA INCG Gift	Director	GGift	−2,000 sh	—	—	6,585

Recent filings

Accepted (ET)
Jul 304
LEFKOFF KYLE0001209191-19-043780
SEC(opens sec.gov)
Feb 84
LEFKOFF KYLE0001562180-19-000863
SEC(opens sec.gov)
Oct 294
LEFKOFF KYLE0001562180-18-004315
SEC(opens sec.gov)
Aug 174/A
LEFKOFF KYLE0001562180-18-003681
SEC(opens sec.gov)
Jul 64
LEFKOFF KYLE0001209191-18-041857
SEC(opens sec.gov)

Companies

Address

1900 NINTH STREET, STE 200

BOULDER, CO, 80302